Single-cell data-driven design of armed oncolytic virus and combination therapy to activate a cooperative innate-adaptive immunity against cancer.
Zhao J, Wang H, Wang C, Li F, Chen J, Zhou F, Zhu Y, Chen J, Liu J, Zheng H, Gong N, Du Y, Zhang Y, Deng L, Du Y, Liu Y, Li Y, Li N, Zhang H, Ding D, Yu S, Zhang C, Yan Y, Wang W, Cao Y, Zhang Y, Zhang H.
Zhao J, et al. Among authors: gong n.
Mol Ther. 2024 Dec 13:S1525-0016(24)00816-5. doi: 10.1016/j.ymthe.2024.12.017. Online ahead of print.
Mol Ther. 2024.
PMID: 39674886
Free article.